期刊文献+

慢性心力衰竭器械治疗进展 被引量:2

Update on device therapy for chronic heart failure
下载PDF
导出
摘要 心力衰竭是心血管疾病患者死亡的重要原因之一,已成为全球心血管疾病治疗新的挑战。药物治疗能改善症状,降低病死率。近年来,越来越多的临床试验和注册研究证据证实,器械治疗能在药物治疗基础上,进一步降低心力衰竭患者的病死率,逆转左室重构,改善生活质量。心力衰竭的器械治疗最初主要是再同步化治疗、植入式心律转复除颤器,近年来还出现了心肌收缩力调节器、左室辅助装置、迷走神经及脊髓刺激等多种器械治疗方式。本文就心力衰竭器械治疗的最新进展进行综述。 Objective:Heart failure, as one of the major reason for cardiovascular death, has emerged as a new challenge for the burden of global cardiovascular disease. Medication therapy can relief symptoms and reduce mortality of heart failure patients. Recently,device-based therapy has been validated by large sample size of clinical trials to be effective treatment by reducing mortalities, reversing ventricular remodeling, and improving life quality of patients with severe heart failure. The present review discussed current devicebased therapies for chronic heart failure including cardiac resynchronization therapy, implantable cardioverter defibrillator, cardiac contractility modulation, percutaneous ventricular restoration, vagus nerve and spinal cord stimulation.
作者 樊晓寒 华伟
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第4期385-389,共5页 Journal of Nanjing Medical University(Natural Sciences)
关键词 心力衰竭 器械治疗 心脏再同步治疗 心肌收缩力调节 heart failure device-based therapy cardiac resynchronization therapy cardiac contractility modulation
  • 相关文献

参考文献19

  • 1Memurray J J, Adamopoulos S,Anker SD,et al. ESC guide- lines for the diagnosis and treatment of acute and chronic heart failure 2012:The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology.Developed in collabora- tion with the Heart Failure Association(HFA)of the ESC [J]. Eur J Heart Fail,2012,14(8):803-869. 被引量:1
  • 2Leyva F,Nisam S,Auricchio A. 20 years of cardiac resyn- chronization therapy[J]. J Am Coll Cardiol, 2014,64(10) : 1047-1058. 被引量:1
  • 3Shetty AK,Duckett SG,Bostock J,et al. Use of a quadripolar left ventricular Lead to achieve successful implantation in patients with previous failed attempts at cardiac resyn- chronization therapy[J]. Europace,2011,13(7) :992-996. 被引量:1
  • 4Pappone C, Calovi c Z, Vicedomini G, et al. Improving car- diac resynchronization therapy response with muhipoint left ventricular pacing:Twelve-month follow-up study[J]. Heart Rhythm,2015,12(6) : 1250-1258. 被引量:1
  • 5Bettin M,Reinke F,Rath B,et al. Recent advances in the entirely subcutaneous ICD System[J]. F1000 Prime Rep, 2015,7:46. 被引量:1
  • 6Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator : 2- year results from a pooled analysis of the IDE study and EFFORTLESS registry[J]. J Am Coll Cardiol,2015,65 (16) : 1605-1615. 被引量:1
  • 7Gold MR, Theuns DA, Knight BP, et al. Head-to-head com- parison of arrhythmia discrimination performance of sub- cutaneous and transvenous ICD arrhythmia detection al- gorithms : the START study [ J ]. J Cardiovasc Electrophys- iol, 2012,23 (4) : 359-366. 被引量:1
  • 8Priori SG,Blomstrom-Lundqvist C,Mazzanti A,et al. 2015 ESC guidelines for the management of patients with ven- tricular arrhythmias and the prevention of sudden cardiac death:the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology(ESC) endorsed by:association for European paediatric and congenital eardiology(AEPC)[J]. Eur heart J,2015 36 (41). 2793-2867. 被引量:1
  • 9Chung MK,Szymkiewicz SJ, Shao M,et al. Aggregate na- tional experience with the wearable cardioverter-defibril- lator: event rates, compliance, and survival [ J ]. J Am Coil Cardiol,2010,56(3) : 194-203. 被引量:1
  • 10Klein HU,Goldenberg I,Moss AJ. Risk stratification for implantable cardioverter defibrillator therapy:the role of the wearable cardioverter-defibriHator[J]. Eur Heart J, 2013,34(29) : 2230-2242. 被引量:1

二级参考文献8

  • 1Cazeau S,Leclercq C,Lavergne T,et al. Effects of multisite biven- tricular pacing in patients with heart failure and intraventricular conduction delay[ J]. N Engl J Med,2001,344:873-880. 被引量:1
  • 2Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure[ J]. N Engl J Med ,2005,352 : 1539-1549. 被引量:1
  • 3Imai M, Rastogi S, Gupta RC, et 81. Therapy with cardiac contrac- tility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure [ J ]. J Am Coil Cardio1,2007 ,49 :2120-2128. 被引量:1
  • 4Morita H, Suzuki G, Haddad W, et al. Cardiac contractility modula- tion with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure[J]. J Card Fail,2003, 9:69-75. 被引量:1
  • 5Morita H, Suzuki G, Haddad W, et al. Long-term effects of non-ex- citatory cardiac contractility modulation electric signals on the pro- gression of heart failure in dogs [ J ]. Eur J Heart Fail, 2004,6 : 145-150. 被引量:1
  • 6Pappone C, Vicedomini G, Salvati A, et al. Electrical modulation of cardiac contractility: clinical aspects in congestive heart failure [J]. Heart Fail Rev,2001,6:55-60. 被引量:1
  • 7Borggrefe MM, Lawo T, Butter C, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure[J]. Eur Heart J,2008 ,29 : 1019-1028. 被引量:1
  • 8Zhang Q, Chan YS, Liang YJ, et al. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with dif- ferent QRS durations [ J ]. Int J Cardiol, 2013,167 : 889- 893. 被引量:1

共引文献8

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部